Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 3 studies | 33% ± 10% |
Insufficient scRNA-seq data for expression of HCRTR2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 72% | 19.48 | 1898 / 2642 | 2% | 0.04 | 12 / 705 |
| ovary | 61% | 6.77 | 109 / 180 | 2% | 0.10 | 9 / 430 |
| lung | 57% | 4.46 | 328 / 578 | 3% | 0.10 | 36 / 1155 |
| heart | 57% | 6.53 | 495 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 16% | 0.90 | 40 / 258 | 21% | 3.01 | 49 / 230 |
| kidney | 36% | 3.21 | 32 / 89 | 0% | 0.02 | 3 / 901 |
| adipose | 33% | 2.48 | 396 / 1204 | 0% | 0 | 0 / 0 |
| breast | 19% | 1.20 | 86 / 459 | 4% | 0.31 | 48 / 1118 |
| uterus | 15% | 0.72 | 25 / 170 | 5% | 0.29 | 22 / 459 |
| muscle | 14% | 0.76 | 116 / 803 | 0% | 0 | 0 / 0 |
| skin | 10% | 0.48 | 187 / 1809 | 1% | 0.01 | 4 / 472 |
| intestine | 10% | 0.55 | 99 / 966 | 0% | 0 | 0 / 527 |
| blood vessel | 9% | 0.74 | 126 / 1335 | 0% | 0 | 0 / 0 |
| thymus | 7% | 0.31 | 47 / 653 | 0% | 0 | 0 / 605 |
| prostate | 7% | 0.28 | 16 / 245 | 0% | 0.01 | 2 / 502 |
| liver | 7% | 0.26 | 15 / 226 | 0% | 0.00 | 1 / 406 |
| esophagus | 6% | 0.30 | 89 / 1445 | 1% | 0.01 | 1 / 183 |
| stomach | 5% | 0.25 | 17 / 359 | 2% | 0.03 | 5 / 286 |
| bladder | 5% | 0.38 | 1 / 21 | 1% | 0.02 | 3 / 504 |
| pancreas | 3% | 0.14 | 9 / 328 | 1% | 0.01 | 1 / 178 |
| spleen | 2% | 0.13 | 6 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 0.04 | 7 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007631 | Biological process | feeding behavior |
| GO_0051480 | Biological process | regulation of cytosolic calcium ion concentration |
| GO_0007218 | Biological process | neuropeptide signaling pathway |
| GO_0032870 | Biological process | cellular response to hormone stimulus |
| GO_0040011 | Biological process | locomotion |
| GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO_0007268 | Biological process | chemical synaptic transmission |
| GO_0010840 | Biological process | regulation of circadian sleep/wake cycle, wakefulness |
| GO_0022410 | Biological process | circadian sleep/wake cycle process |
| GO_0045202 | Cellular component | synapse |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0042277 | Molecular function | peptide binding |
| GO_0017046 | Molecular function | peptide hormone binding |
| GO_0008188 | Molecular function | neuropeptide receptor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0016499 | Molecular function | orexin receptor activity |
| Gene name | HCRTR2 |
| Protein name | Orexin type-2 receptor isoform 2 Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2) Orexin receptor type 2 (Hypocretin receptor type 2) |
| Synonyms | |
| Description | FUNCTION: Nonselective, high-affinity receptor for both orexin-A and orexin-B neuropeptides . Triggers an increase in cytoplasmic Ca(2+) levels in response to orexin-A binding . . |
| Accessions | O43614 S4X0W3 Q548Y0 ENST00000370862.4 S4WX84 ENST00000615358.4 |